Streetbeat News

Earnings

AEYE

AudioEye's shares surged following the announcement of mixed Q4 financial results and the issuance of future guidance.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 12:11 pm

VSCO

Victoria's Secret & Co. shares are trading lower following the release of mixed Q4 financial results and the issuance of guidance. The company's performance and future outlook have impacted investor sentiment, leading to a decrease in stock price.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 12:11 pm

INFN

Infinera's shares are trading lower following the announcement of their preliminary Q4 financial results.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 12:11 pm

RSI

Rush Street Interactive's shares surged following the announcement of Q4 financial results that exceeded expectations, along with a 2024 revenue forecast surpassing estimates.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 12:10 pm

CDMO

Avid Bioservices shares dropped following the announcement of preliminary Q3 financial results and a proposed $160 million private placement of convertible notes. The move indicates potential concerns over dilution or financial health.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 12:10 pm

NMRA

Neumora Therapeutics reported a Q4 EPS loss of $0.71, missing the consensus estimate of $0.55 by 29.09%.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 12:10 pm

ASPS

Altisource Portfolio (ASPS) reported Q4 adjusted EPS of $(0.37), beating the $(0.42) estimate, but missed sales estimates with $32.21M against the expected $36.35M. This represents an EPS improvement and a slight sales decrease from the previous year.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 12:09 pm

PMTS

CPI Card (NASDAQ:PMTS) reported Q4 earnings of $0.23 per share, missing the $0.32 estimate, and sales of $102.87M, missing the $104.70M estimate. This represents a significant decrease from the same period last year, with earnings down 78.3% and sales down 18.64%.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 12:07 pm

OPTN

Optinose reported its fourth quarter and full year 2023 net revenue for Xhance at $19.9 million and $71 million, respectively.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 12:06 pm

CMMB

Chemomab Therapeutics (NASDAQ:CMMB) reported a significant improvement in its Q4 earnings, with losses per share decreasing to $(0.26) from $(0.72) YoY, marking a 63.89% increase in performance.

Portfolio Pulse from mahesh@benzinga.com

March 07, 2024 | 12:06 pm